首页|2019-2021年重症监护病房多重耐药菌医院感染特点分析

2019-2021年重症监护病房多重耐药菌医院感染特点分析

扫码查看
目的 分析 2019-2021 年重症监护病房多重耐药菌医院感染的特点.方法 回顾性选取 2019 年1 月至 2021 年 12 月我院重症监护病房收治的 2 126 例患者的临床资料.分析 2019-2021 年重症监护病房多重耐药菌医院感染的发生情况与多重耐药菌医院感染病原菌的构成情况以及不同部位多重耐药菌医院感染的发生情况.结果 2019-2021 年多重耐药菌医院感染率呈逐年降低趋势.2021 年的多重耐药菌医院感染率低于2019年,差异具有统计学意义(P=0.019).2019-2021年共检出菌株数 64 株,其中耐碳青霉烯类鲍曼不动杆菌在多重耐药菌医院感染的病原菌构成中占比最高(62.50%).重症监护病房多重耐药菌医院感染以呼吸机相关为主,占比为 48.44%;下呼吸道次之,占比为 32.81%;泌尿道、尿管相关、上呼吸道占比均较低,分别为 7.81%、7.81%、3.13%.耐碳青霉烯类鲍曼不动杆菌、耐碳青霉烯类肠杆菌科细菌对头孢吡肟、亚胺培南、美罗培南、阿米卡星及左氧氟沙星的耐药性较高(超过 80%),耐碳青霉烯类铜绿假单胞菌对亚胺培南的耐药性较高.结论 重症监护病房多重耐药菌医院感染是医院感染控制的难点及重点,应根据重症监护病房多重耐药菌医院感染的特点在诊疗中采取针对性防控措施,尤其需重视耐碳青霉烯类鲍曼不动杆菌及呼吸机相关患者重症监护病房医院感染的监测与防控,并合理使用抗菌药物.
Analysis of nosocomial infection characteristics of multi-drug resistant bacteria in intensive care unit from 2019 to 2021
Objective To analyze the nosocomial infection characteristics of multi-drug resistant bacteria in intensive care unit from 2019 to 2021.Methods The clinical data of 2 126 patients admitted in the intensive care unit of our hospital from January 2019 to December 2021 were retrospectively selected.The incidence of nosocomial infection of multi-drug resistant bacteria in intensive care unit from 2019 to 2021,the composition of pathogenic bacteria of nosocomial infection of multi-drug resistant bacteria and the incidence of nosocomial infection of multi-drug resistant bacteria in different parts were analyzed.Results From 2019 to 2021,the nosocomial infection rate of multi-drug resistant bacteria showed a decreasing trend year by year.The nosocomial infection rate of multi-drug resistant bacteria in 2021 was lower than that in 2019,and the difference was statistically significant(P=0.019).From 2019 to 2021,a total of 64 strains were detected,of which Carbapenem-resistant Acinetobacter baumannii accounted for the highest proportion(62.50%)of the pathogenic bacteria in the multi-drug resistant bacteria nosocomial infection.The nosocomial infection of multi-drug resistant bacteria in intensive care unit was mainly ventilator-associated,accounting for 48.44%;the lower respiratory tract was the second,accounting for 32.81%;the proportion of urinary tract,urinary catheter and upper respiratory tract were low,accounting for 7.81%,7.81%and 3.13%respectively.Carbapenem-resistant Acinetobacter baumannii and Carbapenem-resistant Enterobacteriaceae were highly resistant to cefepime,imipenem,meropenem,amikacin and levofloxacin(more than 80%).Carbapenem-resistant Pseudomonas aeruginosa was highly resistant to imipenem.Conclusion Nosocomial infection of multi-drug resistant bacteria in intensive care unit is the difficulty and focus of nosocomial infection control.Targeted prevention and control measures should be taken in the diagnosis and treatment according to the characteristics of nosocomial infection of multi-drug resistant bacteria in intensive care unit.In particular,it is necessary to pay attention to the monitoring and prevention and control of nosocomial infection in intensive care unit of Carbapenem-resistant Acinetobacter baumannii and ventilator-associated patients,and rational use of antibiotics.

intensive care unitmulti-drug resistant bacterianosocomial infectionpathogenic bacteria

孙嘉慧、于燕、张丽心、汪静

展开 >

西安市红会医院控感办,陕西 西安,710054

西安市红会医院检验科,陕西 西安,710054

西安市红会医院临床药学科,陕西 西安,710054

重症监护病房 多重耐药菌 医院感染 病原菌

陕西省重点研发计划

2018SF-146

2024

临床医学研究与实践

临床医学研究与实践

ISSN:
年,卷(期):2024.9(10)
  • 13